Dampak Merokok terhadap Covid-19
Abstract
Gangguan utama dari COVID-19 adalah sistem pernafasan, maka merokok dan penggunaan rokok dapat menjadi orang yang memiliki risiko tinggi untuk mengalami infeksi paru- paru yang parah. Beberapa ulasan dan laporan kasus yang menyajikan data tentang merokok dan COVID-19 memberikan kesimpulan berbeda. Hal ini membuat penulis tertarik untuk menyajikan ulasan sistematis tentang bagaimana tingkat keparahan gejala COVID-19 pada pasien dengan riwayat merokok agar dapat memberikan gambaran lebih lengkap tentang hubungan merokok dan gejala COVID. Artikel dicari melalui basis data sejak Januari – November 2020 . Pencarian diperoleh dari berbagai basis data seperti: PUBMED dan Google Scholar. Kata kunci yang digunakan adalah “smoking and COVID-19” ATAU “Comorbid and smoking and COVID-19”, ATAU “ Kebiasaan merokok dan COVID-19”. Free full text berbahasa Inggris atau Indonesia. Subyek merupakan pasien terkonfirmasi melalui real time PCR (RT-PCR) sebagai penderita COVID-19. Desain observasional berupa COHORT retrospektif. Berdasarkan hasil tinjauan didapatkan 13 artikel yang memenuhi kriteria inklusi dan mengestimasi bahwa pasien COVID-19 yang memiliki kebiasaan merokok yang dilakukan sebelum pandemi berpotensi 2 kali lebih mungkin mengalami perburukan gejala, peningkatan kemungkinan dirawat di ICU bahkan kematian.
References
Bauer, C. M. T., Morissette, M. C. and Stämpfli, M. R. (2013) ‘The influence of cigarette smoking on viral infections: Translating bench science to impact COPD pathogenesis and acute exacerbations of COPD clinically’, Chest. doi: 10.1378/chest.12-0930.
Chen, R. et al. (2020) ‘COVID-19 with Different Severities : A Multicenter Study of clinical features’, 201(11), pp. 1380–1388. doi: 10.1164/rccm.202002-0445OC.
Chen, T. et al. (2020) ‘Clinical characteristics of 113 deceased patients with coronavirus disease 2019: Retrospective study’, The BMJ, 368. doi: 10.1136/bmj.m1091.
Dong, X. et al. (2020) ‘Eleven faces of coronavirus disease 2019’, Allergy: European Journal of Allergy and Clinical Immunology, 75(7), pp. 1699–1709. doi: 10.1111/all.14289.
Feldman, C. and Anderson, R. (2013) ‘Cigarette smoking and mechanisms of susceptibility to infections of the respiratory tract and other organ systems’, Journal of Infection. doi: 10.1016/j.jinf.2013.05.004.
Feng, Y. et al. (2020) ‘Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study’, International Journal of Infectious Diseases, 395(7), pp. 2–5. doi: 10.1093/ntr/ntaa082.
Guan, W. et al. (2020) ‘Clinical Characteristics of Coronavirus Disease 2019 in China’, New England Journal of Medicine, 382(18), pp. 1708–1720. doi: 10.1056/nejmoa2002032.
Goyal P, Choi JJ, Pinheiro LC, et al. Clinical characteristics of Covid-19 in New York City [published online ahead of print April 17, 2020]. N Engl J Med. 2020. doi:10.1056/NEJMc2010419.
Holshue, M. L. et al. (2020) ‘First Case of 2019 Novel Coronavirus in the United States’, New England Journal of Medicine. doi: 10.1056/nejmoa2001191.
Handayani, R. T., Arradini, D., Darmayanti, A. T., Widiyanto, A., & Atmojo, J. T. (2020). Pandemic Covid-19, Body Immunity Response, and Herd Immunity. Jurnal Ilmiah Permas: Jurnal Ilmiah STIKES Kendal, 10(3), 373-380.
Kim, E. S. et al. (2020) ‘Clinical course and outcomes of patients with severe acute respiratory syndrome coronavirus 2 infection: A preliminary report of the first 28 patients from the korean cohort study on COVID-19’, Journal of Korean Medical Science, 35(13), pp. 1–12. doi: 10.3346/JKMS.2020.35.E142.
Liberati, A. et al. (2009) ‘The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration’, Bmj, 339(jul21 1), pp. b2700–b2700. doi: 10.1136/bmj.b2700.
Mo, P. et al. (2020) ‘Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China’, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. doi: 10.1093/cid/ciaa270.
Park, J. E., Jung, S. and Kim, A. (2018) ‘MERS transmission and risk factors: A systematic review’, BMC Public Health. doi: 10.1186/s12889-018-5484-8.
Patanavanich, R. and Glantz, S. A. (2020) ‘Smoking Is Associated With COVID-19 Progression: A Meta-analysis’, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco, 22(9), pp. 1653–1656. doi: 10.1093/ntr/ntaa082.
Shi, Y. et al. (2020) ‘Host susceptibility to severe COVID-19 and establishment of a host risk score: Findings of 487 cases outside Wuhan’, Critical Care, 24(1), pp. 2–5. doi: 10.1186/s13054-020-2833-7.
Vardavas, C. I. and Nikitara, K. (2020) ‘COVID-19 and smoking: A systematic review of the evidence’, Tobacco Induced Diseases, 18(March), pp. 1–4. doi: 10.18332/tid/119324.
Wan, S. et al. (2020) ‘Clinical features and treatment of COVID-19 patients in northeast Chongqing’, Journal of Medical Virology, 92(7), pp. 797–806. doi: 10.1002/jmv.25783.
Yao, Q. et al. (2020) ‘A retrospective study of risk factors for severe acute respiratory syndrome coronavirus 2 infections in hospitalized adult patients’, Polish Archives of Internal Medicine, 130(5), pp. 390–399. doi: 10.20452/pamw.15312.
Zhang, X. et al. (2020) ‘Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings’, International Journal of Infectious Diseases, 94, pp. 81–87. doi: 10.1016/j.ijid.2020.03.040.
Zhou, F. et al. (2020) ‘Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study’, The Lancet, 395(10229), pp. 1054–1062. doi: 10.1016/S0140-6736(20)30566-3.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
